Streetbeat News

Earnings

BP

BP's stock fell 1.70% to $30.99 as crude oil prices dropped over 6% due to Israeli airstrikes in Iran, which did not affect oil infrastructure. This decline comes ahead of BP's Q3 earnings report, highlighting the company's sensitivity to oil price fluctuations. Despite diversification into renewables, BP's earnings remain heavily tied to oil prices.

Portfolio Pulse from Henry Khederian

October 28, 2024 | 3:28 pm

RGC

Regencell Bioscience reported a quarterly loss of $(0.33) per share, an improvement from the $(0.45) per share loss in the same period last year, marking a 26.67% increase.

Portfolio Pulse from Benzinga Newsdesk

October 28, 2024 | 3:18 pm

ENSG

Ensign Group (NASDAQ:ENSG) reported Q3 earnings that missed EPS estimates but beat revenue expectations. The company narrowed its FY24 EPS guidance and raised its revenue forecast. Analysts have adjusted their price targets upwards following the earnings announcement.

Portfolio Pulse from Avi Kapoor

October 28, 2024 | 3:14 pm

AAPL

AMZN

GOOG

META

MSFT

QQQ

The Nasdaq 100's performance this week hinges on earnings reports from five major tech companies: Apple, Amazon, Alphabet, Meta, and Microsoft. The Invesco QQQ Trust Series 1 (QQQ) is in a resistance zone, and a positive earnings spark could lead to a breakout. Money flows are positive in major tech stocks and ETFs like QQQ and SPY. Meanwhile, oil prices have fallen due to geopolitical tensions, and the Japanese yen is weakening, impacting Japanese stocks.

Portfolio Pulse from The Arora Report

October 28, 2024 | 3:10 pm

NOV

NOV Inc. reported weaker-than-expected Q3 results, missing both revenue and earnings estimates. Despite improvements in cash flow and margins, analysts have lowered their price targets for NOV. The company expects a decline in Q4 revenues. NOV shares rose slightly by 0.4%.

Portfolio Pulse from Avi Kapoor

October 28, 2024 | 3:06 pm

RITM

Rithm Capital (NYSE:RITM) is set to release its quarterly earnings report on October 29, 2024. Analysts expect an EPS of $0.42. The company's past performance shows that even with an EPS beat, share prices have sometimes declined. Investors are keen on the guidance provided alongside the earnings.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 3:03 pm

QRVO

Qorvo is set to release its quarterly earnings report on October 29, 2024, with analysts expecting an EPS of $1.85. The market is optimistic about Qorvo surpassing estimates and providing positive guidance. The company's past performance shows mixed results, with a recent EPS beat leading to a slight share price increase. Analysts have a Neutral consensus on Qorvo, with a 24.44% potential upside based on the average price target. Qorvo's financial metrics show strong revenue growth but challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 3:03 pm

CBZ

CBIZ (NYSE:CBZ) is set to release its quarterly earnings report on October 29, 2024, with analysts estimating an EPS of $0.76. The company's past performance shows mixed results, but shares have increased by 28% over the past year. Analysts have a 'Buy' rating with a price target of $86, indicating a potential 29.54% upside.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 3:03 pm

IPGP

IPG Photonics (NASDAQ:IPGP) is set to release its quarterly earnings on October 29, 2024. Analysts estimate an EPS of $0.19. The company's past performance shows mixed results, with a recent miss leading to a slight share price drop. Analysts maintain a 'Buy' rating with a $100 price target, indicating a potential 30.17% upside. IPG Photonics faces challenges in revenue growth but excels in net margin and return on assets.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 3:03 pm

CROX

Crocs (NASDAQ:CROX) is set to release its quarterly earnings on October 29, 2024. Analysts expect an EPS of $3.10. The company's past performance shows mixed results, with a notable EPS beat last quarter but a subsequent share price drop. Crocs has an 'Outperform' rating from analysts, with a 24.36% potential upside based on a $166.33 price target. Despite strong net margins and ROE, Crocs faces challenges with a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

October 28, 2024 | 3:02 pm